Unknown

Dataset Information

Microfluidic fabrication of lipid nanoparticles for the delivery of nucleic acids.


ABSTRACT: Gene therapy has emerged as a potential platform for treating several dreaded and rare diseases that would not have been possible with traditional therapies. Viral vectors have been widely explored as a key platform for gene therapy due to their ability to efficiently transport nucleic acid-based therapeutics into the cells. However, the lack of precision in their delivery has led to several off-target toxicities. As such, various strategies in the form of non-viral gene delivery vehicles have been explored and are currenlty employed in several therapies including the SARS-CoV-2 vaccine. In this review, we discuss the opportunities lipid nanoparticles (LNPs) present for efficient gene delivery. We also discuss various synthesis strategies via microfluidics for high throughput fabrication o

SUBMITTER: Prakash G 

PROVIDER: S-EPMC9035142 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature